Health Trials

High-risk Large B-cell Lymphoma (LBCL)

1

Review clinical trials related to High-risk Large B-cell Lymphoma (LBCL). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Injection as First-Line Therapy of High-Risk Large B-Cell Lymphoma

The goal of this is Single-Arm, Multicenter, Open-Label Clinical Study is to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Injection(Axi-cel) as First-Line Therapy of High-Risk Large B-Cell Lymphoma.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Ruijin HospitalUpdated: Apr 22, 2025Locations: 1
Eligibility criteria

Histologically confirmed LBCL (Large B-Cell Lymphoma) according to the WHO 2016... [+11]

LBCL with T-cell/histiocyte-rich background [+14]

Read more